Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
12.33
+0.36 (3.01%)
At close: Aug 13, 2026, 4:00 PM EDT
11.87
-0.46 (-3.73%)
Pre-market: Aug 14, 2026, 4:01 AM EDT
Telix Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Telix Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $21.1. The average 1-year stock price forecast is 71.13% higher than the current stock price, while the lowest is $19.73 (+60.02%) and the highest is $22.27 (+80.62%).
Price Target: $21.1 (+71.13%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Telix Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
943.81M
from 803.79M
Increased by 17.42%
Revenue Next Year
1.09B
from 943.81M
Increased by 15.27%
EPS This Year
0.00
from -0.02
EPS Next Year
0.05
from 0.00
Increased by 1,019.74%
EPS and Forward PE are based on non-GAAP adjusted numbers.